Immediate Impact
62 standout
Citing Papers
Robotic wireless capsule endoscopy: recent advances and upcoming technologies
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Siegbert Faiss being referenced
Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
2003
Ultra-High-Dose Lanreotide Treatment in Patients with Metastatic Neuroendocrine Gastroenteropancreatic Tumors
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Siegbert Faiss | 568 | 433 | 832 | 695 | 86 | 1.6k | |
| Henryk Dancygier | 766 | 501 | 738 | 480 | 66 | 1.5k | |
| Bernhard Stamm | 498 | 143 | 818 | 878 | 48 | 1.4k | |
| Paola Spaggiari | 499 | 253 | 672 | 345 | 78 | 1.4k | |
| F Burcharth | 1057 | 470 | 708 | 624 | 125 | 2.0k | |
| Daniel Pérez | 575 | 334 | 573 | 204 | 71 | 1.5k | |
| Shojiroh Morinaga | 731 | 483 | 373 | 229 | 84 | 1.5k | |
| J Hémet | 439 | 247 | 313 | 247 | 116 | 1.5k | |
| Andreas Püspök | 1097 | 739 | 676 | 293 | 74 | 2.2k | |
| Dimitra Rontogianni | 278 | 258 | 452 | 191 | 86 | 1.3k | |
| G. Monges | 961 | 686 | 880 | 268 | 79 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...